U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07681375) titled 'Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor' on May 18.

Brief Summary: To evaluate the feasibility of the DexBasal Study System

Study Start Date: April 11, 2023

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes

Intervention: DRUG: Basal insulin

daily basal insulin dose

DEVICE: Dexcom Continuous Glucose Monitoring (CGM)

Dexcom Continuous Glucose Monitoring (CGM) Sensor

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: DexCom, Inc.

Disclaimer: Curated by HT Syndication....